Demo Sign up Log In

Ligand Pharmaceuticals Inc (LGND)

R&D Expenses

$41.35M

TTM · Period ending: Jun 30, 2026 · USD

LGND R&D Expenses

Latest reported$41.35Mperiod endingJun 30, 2026

Latest reported$41.35Mperiod endingJun 30, 2026

LGND TTM R&D Expenses ($0.00 → $41.35M)

TTM R&D Expenses

High-resolution chart · PNG

LGND r&d expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Ligand Pharmaceuticals Inc R&D Expenses — Trailing twelve months (TTM) (USD)
Period ending	R&D Expenses (USD)
Jun 30, 2001	51,632,000
Mar 31, 2001	51,207,000
Dec 31, 2000	51,300,000
Sep 30, 2000	53,093,000
Jun 30, 2000	55,564,000
Mar 31, 2000	57,398,000
Dec 31, 1999	59,400,000
Sep 30, 1999	66,300,000
Jun 30, 1999	67,600,000
Mar 31, 1999	70,300,000
Dec 31, 1998	70,700,000
Sep 30, 1998	70,200,000
Jun 30, 1998	71,200,000
Mar 31, 1998	70,600,000
Dec 31, 1997	72,300,000
Sep 30, 1997	68,600,000
Jun 30, 1997	65,600,000
Mar 31, 1997	63,700,000
Dec 31, 1996	59,400,000
Sep 30, 1996	55,400,000
Jun 30, 1996	52,500,000
Mar 31, 1996	37,700,000
Dec 31, 1995	32,400,000
Sep 30, 1995	19,100,000
Jun 30, 1995	7,000,000
Mar 31, 1995	7,000,000
Dec 31, 1994	0

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.